Subscribe To
Allogene therapeutics announces participation in november investor conferences
SOUTH SAN FRANCISCO, Calif., Oct. 30, 2023 (GLOBE NEWSWIRE) -- Allogene Therapeutics, Inc. (Nasdaq: ALLO), a clinical-stage biotechnology company pion...
October 30, 2023, 8:30 am
Icad to report third quarter 2023 financial results on november 13, 2023
NASHUA, N.H., Oct. 30, 2023 (GLOBE NEWSWIRE) -- iCAD, Inc. (NASDAQ: ICAD) is a global leader on a mission to create a world where ...
October 30, 2023, 8:00 am
Kura oncology to participate in three upcoming investor conferences
SAN DIEGO, Oct. 30, 2023 (GLOBE NEWSWIRE) -- Kura Oncology, Inc. (Nasdaq: KURA), a clinical-stage biopharmaceutical company committed to realizing the...
October 30, 2023, 7:30 am
Intuitive machines stock climbs on lunar mission plan as mcdonald's edges higher ahead of results
Coherus BioSciences stock CHRS, -3.65% rose 17% as the Food and Drug Administration approved its treatment for nasopharyngeal ...
October 30, 2023, 5:20 am
Gsk says endometrial cancer drug meets primary goal in late-stage trial
British drugmaker GSK said on Monday its cancer drug Jemperli met the primary goal of overall survival ...
October 30, 2023, 3:16 am
Xencor: data in early 2024 could bring shareholder value
Xencor is expected to release data from a phase 2 study in early 2024 targeting patients with mCRPC and gynecological ...
October 27, 2023, 11:56 am
Oncology drugs market set to hit $347.3 billion by 2032 driven by rising cancer prevalence: persistence market research
Increased investments in oncology medications and research, fueled by rising cancer prevalence, offer g...
October 27, 2023, 11:31 am
Edap: expecting commercial success in prostate cancer with pipeline expansion
EDAP TMS reported Q2 2023 revenues of $15.52 million, a 0.9% YoY growth that missed estimates. In Q2 2023, HIFU's total revenue growth stood at 63.6% ...
October 27, 2023, 5:33 am
Huge social media chatter that putin is dead (spoiler - he is not)
Via the UK's Daily Mail:The Kremlin has issued an extraordinary denial to the 'lies' that Vladimir Putin, 71, had 'died at his luxury Valdia forest pa...
October 27, 2023, 2:17 am
Bristol myers squibb revenue falls on generic competition for key drug
Shares of Bristol Myers Squibb (BMY) fell Thursday after the company reported that sales of the drug maker's popular Revlimid blood ...
October 26, 2023, 4:55 pm
Why novocure stock was sick today
The cancer treatment device developer released its latest set of quarterly results. These were a mixed ...
October 26, 2023, 4:35 pm
Merck's profit beats estimates on sales of its cancer, covid-19 drugs and hpv shot
Merck (MRK) posted better-than-expected results on strong sales of its popular Keytruda cancer drug and...
October 26, 2023, 4:25 pm
Bristol myers squibb earnings top estimates even as top-selling drug fights generic competition
Bristol Myers Squibb's revenue was in line with estimates, but fell slightly from the same period last year due to lower sales of blood ...
October 26, 2023, 7:05 am
Merck third-quarter results beat estimates, boosted by cancer drug and vaccine growth
Merck & Co. on Thursday reported third-quarter results that topped analysts' expectations, powered by growth in oncology and vaccines....
October 26, 2023, 6:32 am
Edap: french company and a solid revenue generator in its niche
EDAP TMS S.A. is a French developer of minimally invasive medical devices for urological diseases. The company operates in three segments: High Intens...
October 25, 2023, 8:00 pm
Carisma to present first results from in vivo car-m collaboration with moderna at sitc 2023
-Late-breaking abstract to be presented on November 3 rd at 11:30 am PT highlighting pre-clinical data with Moderna -Two additional pre-clinical data ...
October 25, 2023, 9:11 am
Sensei biotherapeutics to present initial clinical data from dose escalation trial of sns-101 at 2023 sitc annual meeting
BOSTON, Oct. 25, 2023 (GLOBE NEWSWIRE) -- Sensei Biotherapeutics, Inc. (Nasdaq: SNSE), a clinical stage immuno-oncology company focused on the discove...
October 25, 2023, 9:05 am
Adaptimmune to report q3 2023 financial and business updates on wednesday, november 8, 2023
Philadelphia, Pennsylvania and Oxfordshire, United Kingdom--(Newsfile Corp. - October 25, 2023) - Adaptimmune Therapeutics plc (Nasdaq: ADAP), a leade...
October 25, 2023, 8:06 am
Fate therapeutics to webcast conference call reporting third quarter 2023 financial results
SAN DIEGO, Oct. 25, 2023 (GLOBE NEWSWIRE) -- Fate Therapeutics, Inc. (the “Company” or “Fate Therapeutics”) (NASDAQ: FATE), a clinical-stage ...
October 25, 2023, 8:00 am
Angle technolgy could help provide a more targeted approach to head and neck cancer
ANGLE plc, a leading company in liquid biopsy technology, has unveiled promising research findings that could help transform the treatment of head and...
October 25, 2023, 2:53 am